BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37503601)

  • 1. Trends and Outcomes of Cardiogenic Shock in Patients With End-Stage Renal Disease: Insights From USRDS Database.
    Dalia T; Pothuru S; Chan WC; Mehta H; Goyal A; Farhoud H; Boda I; Malhotra A; Vidic A; Rali AS; Hanff TC; Gupta K; Fang JC; Shah Z
    Circ Heart Fail; 2023 Aug; 16(8):e010462. PubMed ID: 37503601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
    Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
    Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes.
    Yandrapalli S; Sanaani A; Harikrishnan P; Aronow WS; Frishman WH; Lanier GM; Ahmed A; Fonarow GC
    Am Heart J; 2019 Jul; 213():18-29. PubMed ID: 31078113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Healthcare Resource Utilization of Percutaneous Mechanical Circulatory Support Using Impella Versus Intra-aortic Balloon Pump Use for Patients With Acute Coronary Syndrome and Cardiogenic Shock Undergoing Percutaneous Coronary Interventions: Insights From National Inpatient Sample.
    Dodoo SN; Kwapong YA; Agyemang-Sarpong A; Amoran E; Egolum UO; Ghasemzadeh N; Ramadan R; Henry G; Samady H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102053. PubMed ID: 37640173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women.
    Alasnag M; Truesdell AG; Williams H; Martinez SC; Qadri SK; Skendelas JP; Jakobleff WA; Alasnag M
    Curr Atheroscler Rep; 2020 Apr; 22(3):11. PubMed ID: 32328843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shock.
    Pahuja M; Chehab O; Ranka S; Mishra T; Ando T; Yassin AS; Thayer KL; Shah P; Kimmelstiel CD; Salehi P; Kapur NK
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):217-225. PubMed ID: 32352638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender Differences in the Outcomes of Cardiogenic Shock Requiring Percutaneous Mechanical Circulatory Support.
    Bravo-Jaimes K; Mejia MO; Abelhad NI; Zhou Y; Jumean MF; Nathan S; Dhoble A
    Am J Cardiol; 2022 Jul; 174():20-26. PubMed ID: 35469654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock.
    Hernandez-Montfort J; Sinha SS; Thayer KL; Whitehead EH; Pahuja M; Garan AR; Mahr C; Haywood JL; Harwani NM; Schaeffer A; Wencker D; Kanwar M; Vorovich E; Abraham J; Burkhoff D; Kapur NK
    Circ Heart Fail; 2021 May; 14(5):e007924. PubMed ID: 33905259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.
    Yang JH; Choi KH; Ko YG; Ahn CM; Yu CW; Chun WJ; Jang WJ; Kim HJ; Kim BS; Bae JW; Lee SY; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Lim SH; Cho S; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Gwon HC
    Circ Heart Fail; 2021 Jun; 14(6):e008141. PubMed ID: 34129366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Pahuja M; Ranka S; Chehab O; Mishra T; Akintoye E; Adegbala O; Yassin AS; Ando T; Thayer KL; Shah P; Kimmelstiel CD; Salehi P; Kapur NK
    Catheter Cardiovasc Interv; 2021 May; 97(6):1129-1138. PubMed ID: 32473083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers.
    Wang JI; Lu DY; Mhs ; Feldman DN; McCullough SA; Goyal P; Karas MG; Sobol I; Horn EM; Kim LK; Krishnan U
    J Am Heart Assoc; 2020 Dec; 9(23):e017326. PubMed ID: 33222608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock.
    Miller PE; Solomon MA; McAreavey D
    Crit Care Med; 2017 Nov; 45(11):1922-1929. PubMed ID: 28857849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock.
    Shibasaki I; Masawa T; Abe S; Ogawa H; Takei Y; Tezuka M; Seki M; Kato T; Watanabe R; Koshiji N; Saitou S; Ogata K; Haruyama Y; Toyoda S; Fukuda H
    J Cardiol; 2022 Aug; 80(2):116-124. PubMed ID: 35288000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
    Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary Mechanical Circulatory Support in Cardiogenic Shock due to ST-Elevation Myocardial Infarction: Analysis of the National Readmissions Database.
    Briasoulis A; Kampaktsis P; Emfietzoglou M; Kuno T; Van den Eynde J; Ntalianis A; Duque ER; Malik AH
    Angiology; 2023 Jan; 74(1):31-38. PubMed ID: 35440216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Mechanical Circulatory Support Use and Outcomes of Patients With Cardiogenic Shock in Japan, 2010 to 2020 (from a Nationwide Inpatient Database Study).
    Nishimoto Y; Ohbe H; Matsui H; Nakata J; Takiguchi T; Nakajima M; Sasabuchi Y; Sato Y; Watanabe T; Yamada T; Fukunami M; Yasunaga H
    Am J Cardiol; 2023 Sep; 203():203-211. PubMed ID: 37499600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
    Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
    Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.